Bo Feng
- Epidemiology top 10%
- Hepatology top 2%
- Molecular Biology
- Immunology
- Public Health, Environmental and Occupational Health top 10%
- Co-authors
- David B. SeiferRobert M. SheldenLai WeiHuiying RaoYan GaoDavid T. DenhardtCheryl F. DreyfusShiling Chen
- Topics
- Hepatitis C virus research (41 papers)Liver Disease Diagnosis and Treatment (37 papers)Hepatitis B Virus Studies (32 papers)
- Journals
- SHILAP Revista de lepidopterologíaThe Journal of ImmunologyPLoS ONE
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Bo Feng
91 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 107
- Epidemiology 424
- Hepatology 400
- Molecular Biology 251
- Immunology 187
- Public Health, Environmental and Occupational Health 149
Countries citing papers authored by Bo Feng
This map shows the geographic impact of Bo Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Feng more than expected).
Fields of papers citing papers by Bo Feng
This network shows the impact of papers produced by Bo Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Feng. The network helps show where Bo Feng may publish in the future.
Co-authorship network of co-authors of Bo Feng
This figure shows the co-authorship network connecting the top 25 collaborators of Bo Feng. A scholar is included among the top collaborators of Bo Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Feng. Bo Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 1 | |
| 8 | 4 | |
| 9 | 1 | |
| 10 | 0 | |
| 11 | 25 | |
| 12 | [Dietary microelements intakes status of elderly people from different areas in Zhejiang Province in 2010-2012]. | 1 |
| 13 | 16 | |
| 14 | 19 | |
| 15 | 11 | |
| 16 | 8 | |
| 17 | 15 | |
| 18 | Evaluation of insulin secretion and insulin sensitivity in the selection of hypoglycemic drugs——a multicentre clinical study | 1 |
| 19 | 58 | |
| 20 | 1 |
About Bo Feng
Bo Feng is a scholar working on Hepatology, Epidemiology and Immunology, having authored 100 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hepatitis C virus research (41 papers), Liver Disease Diagnosis and Treatment (37 papers) and Hepatitis B Virus Studies (32 papers). The work is most often cited by research in Hepatology (400 citations), Complementary and alternative medicine (110 citations) and Epidemiology (424 citations). Bo Feng has collaborated with scholars based in China, United States and Canada. Frequent co-authors include David B. Seifer, Robert M. Shelden, Lai Wei, Lai Wei, Huiying Rao, Yan Gao, David T. Denhardt, Cheryl F. Dreyfus, Shiling Chen and Ellen E. Rollo. Their work appears in journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.